Bristol-Myers Squibb Co news

   Watch this stock
Showing stories 1 - 10 of about 169   

Articles published

BMY 49.23 -6.26 (-11.28%)
price chart
Bristol-Myers Squibb Becomes Oversold
But making Bristol-Myers Squibb Co. an even more interesting and timely stock to look at, is the fact that in trading on Friday, shares of BMY entered into oversold territory, changing hands as low as $49.62 per share.
Bristol-Myers Squibb stock sinks 7.2% after it says it won't pursue ...
Bristol-Myers Squibb Co. BMY, -11.28% shares sunk 7.2% in pre-market trade Friday after the company said it wouldn't try for accelerated approval in first-line lung cancer for its combination of Opdivo and Yervoy.
Bristol-Myers Squibb and Ono Pharmaceutical Company Enter Settlement and ...  Business Wire (press release)
Why Bristol-Myers Squibb Co Stock Is Slipping Today  Fox Business
Earnings Roundup: Bristol-Myers Squibb Company (NYSE:BMY)
Bristol-Myers Squibb Company (NYSE:BMY) moved down -1.03% and closed its last trading session at $55.49. This Medical Sector stock currently has the Market Capitalization of 93.28 Billion.
Analyst Downgrades: Bristol-Myers Squibb Co, Teva Pharmaceutical Industries ...
Analysts are weighing in on biotech stocks Bristol-Myers Squibb Co (NYSE:BMY), Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), and Endo International plc - Ordinary Shares (NASDAQ:ENDP).
Investors Catching Stocks: Bristol-Myers Squibb Company (NYSE:BMY)
Bristol-Myers Squibb Company (NYSE:BMY) will report its next earnings on 26-Jan-17. The company reported the earnings of $0.77/Share in the last quarter where the estimated EPS by analysts was $0.65/share.
Bristol-Myers Squibb Company (BMY) Stake Raised by Bartlett & Co. LLC  Sports Perspectives
Bristol-Myers Squibb Co: Bears Will Continue to Ravage BMY Stock  Profit Confidential
Bristol-Myers Squibb Co (NYSE:BMY) Heffx Technical Analysis
During the past 10 bars, there have been 4 white candles and 6 black candles for a net of 2 black candles. During the past 50 bars, there have been 28 white candles and 22 black candles for a net of 6 white candles.
Agree To Purchase Bristol-Myers Squibb Co. At $30, Earn 2.7% Using Options
Investors eyeing a purchase of Bristol-Myers Squibb Co. (Symbol: BMY) shares, but cautious about paying the going market price of $58.88/share, might benefit from considering selling puts among the alternative strategies at their disposal.
Notable Stock Analysts Ratings: Bristol-Myers Squibb Company (NYSE:BMY)  News Oracle
Bank of Montreal Can Has $143004000 Position in Bristol-Myers Squibb Co. (BMY)  Sports Perspectives
Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for January 04, 2017
Bristol-Myers Squibb Company ( BMY ) will begin trading ex-dividend on January 04, 2017. A cash dividend payment of $0.39 per share is scheduled to be paid on February 01, 2017.
Bristol-Myers Squibb Co (NYSE:BMY) Agrees To Extend Research With Five Prime ...  Market Exclusive
It Was CheckMate for Bristol-Myers Squibb Company in 2016  Motley Fool
Bristol-Myers Squibb Co (BMY) Could Benefit From AstraZeneca plc (ADR) (AZN ...
BMO Capital weighed in on AstraZeneca plc (ADR) (NYSE:AZN) recently following the announcement of refined endpoint for Phase III Mystic trial and the delay in immuno-oncology combination data.
AstraZeneca plc (ADR) (AZN) MYSTIC Change Incrementally Positive for Merck ...  Smаrt Stоck Nеws
analysts Recommendations: Bristol-Myers Squibb Company (NYSE:BMY)
Bristol-Myers Squibb Company (NYSE:BMY) will report its next earnings on 26-Jan-17. The company reported the earnings of $0.77/Share in the last quarter where the estimated EPS by analysts was $0.65/share.
Bristol-Myers Squibb Company (BMY) Shares Bought by BlackRock Japan Co. Ltd  Sports Perspectives
Analyst Research Summary: Bristol-Myers Squibb Company (NYSE:BMY)  The Independent Republic